サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1455425

CRISPRおよびcas遺伝子の世界市場レポート 2024

CRISPR And Cas Gene Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
CRISPRおよびcas遺伝子の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

CRISPRおよびcas遺伝子の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には20.5%の年間平均成長率（CAGR）で83億7,000万米ドルに成長すると予想されます。今後予想される成長には、特定の成分の使用禁止が世界的に拡大したこと、意識の高い消費者主義の台頭、市場における新ブランドの出現、消費者教育に重点を置いた取り組み、美容の包括性の促進など、いくつかの要因が挙げられます。予測期間中に予想される主な動向には、技術の進歩、製品革新、美容循環経済の発展、メンズグルーミング部門の成長、美容業界における社会正義と倫理的調達への注目の高まりなどが含まれます。

パーソナライズされた治療への注目の高まりが予想され、将来のCRISPRおよびcas遺伝子市場の成長を促進すると予想されます。個別化療法には、個人の遺伝子プロファイルを利用して、病気の診断、治療、予防に関する決定を行うことが含まれます。 CRISPRとCas遺伝子、特にCas9は、個人の遺伝物質の正確な変更を可能にすることで個別化医療において極めて重要な役割を果たし、遺伝性疾患、がん、さまざまな病状に対する個別化された治療法に画期的な可能性をもたらします。たとえば、米国に拠点を置く専門家会員組織であるPersonalized Medicine Coalitionのデータによると、2022年に食品医薬品局の医薬品評価研究センター（CDER）が37の新しい分子実体（NME）を承認したことが明らかになりました。このうち、約34%に相当する12品目は、個別化医療連合（PMC）によって個別化医療として分類されています。したがって、パーソナライズされた治療に対する需要の高まりが、CRISPRおよびcas遺伝子市場の成長を促進すると予想されます。

CRISPRおよびcas遺伝子市場の主要企業は、製品提供を強化し、競争力を高めるために、CRISPRベースの細胞ベースの遺伝子治療などの革新的な製品を積極的に開発しています。 CRISPRベースの細胞ベースの遺伝子治療には、CRISPR遺伝子編集技術を利用して細胞内の遺伝物質を修飾または修正することが含まれており、遺伝性疾患、疾患、その他の病状を細胞レベルで治療するための標的を絞った潜在的に変革的なアプローチを提供します。たとえば、2023年 12月に、米国に本拠を置くバイオ医薬品会社であるVertex Pharmaceuticals Incorporatedは、米国食品医薬品局（FDA）からCASGEVY（exagamglogene autotemcel[exa-cel]）の承認を取得しました。 CASGEVYは、血管閉塞性危機を繰り返す12歳以上の鎌状赤血球症（SCD）の管理を目的としたCRISPR/Cas9ゲノム編集遺伝子治療です。この初めての治療法は、適格な鎌状赤血球患者に1回限りの革新的な治療法を提供する可能性があります。 Vertexは経験豊富な施設と協力して、幹細胞移植に関する特別なトレーニングを必要とする患者にCASSGEVYを投与するための米国の承認済み治療センター（ATC）のネットワークを確立しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のCRISPRおよびCas遺伝子市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • キットと酵素
  • ライブラリ
  • デザインツール
  • 抗体
  • その他の製品タイプ
  • 世界のCRISPRおよびCas遺伝子市場、サービスタイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 細胞株工学
  • gRNAの設計
  • 微生物の遺伝子編集
  • DNA合成
  • 世界のCRISPRおよびCas遺伝子市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 臨床
  • 金融
  • 運用および管理
  • 世界のCRISPRおよびCas遺伝子市場、最終用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • バイオテクノロジー企業と製薬会社
  • 学術機関および政府調査機関
  • 受託研究機関（CRO）

第7章 地域および国の分析

  • 世界のCRISPRおよびCas遺伝子市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のCRISPRおよびCas遺伝子市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • CRISPRおよびCas遺伝子市場の競合情勢
  • CRISPRおよびCas遺伝子市場の企業プロファイル
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc
    • AstraZeneca plc.
    • Danaher Corporation
    • Quest Diagnostics

第31章 その他の主要および革新的な企業

  • Lonza Group AG
  • Bio-Rad Laboratories Inc.
  • eGenesis
  • Novartis Institutes for BioMedical Research
  • Myriad Genetics Inc.
  • GenScript
  • Takara Bio Inc.
  • 23andMe Inc.
  • Merck KGaA
  • Color Genomics Inc.
  • Horizon Discovery Group Plc
  • Beam Therapeutics Inc
  • Intellia Therapeutics Inc.
  • New England BioLabs
  • Recursion Pharmaceuticals Inc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r16426

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, along with the Cas (CRISPR-associated) gene, particularly Cas9, represents a powerful gene-editing technology. This system enables precise modifications to DNA sequences, revolutionizing genetic research, biotechnology, and potential medical applications.

The primary product types within the CRISPR and Cas genes market include kits and enzymes, libraries, design tools, antibodies, and others. Kits and enzymes are fundamental components in the realm of CRISPR-based gene therapy, with kits containing the necessary ingredients and instruments for gene editing research, and enzymes, such as Cas9, playing a pivotal role in the gene editing process. Services are categorized into cell line engineering, gRNA design, microbial gene editing, and DNA synthesis, and find applications across clinical, financial, operational, and administrative domains. End users of these products and services include biotechnology and pharmaceutical companies, academic and government research institutes, as well as contract research organizations (CROs).

The CRISPR and Cas gene research report is one of a series of new reports from The Business Research Company that provides CRISPR and Cas gene market statistics, including the CRISPR and Cas gene industry's global market size, regional shares, competitors with a CRISPR and Cas gene market share, detailed CRISPR and Cas gene market segments, market trends and opportunities, and any further data you may need to thrive in the CRISPR and Cas gene industry. This CRISPR and Cas gene market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The crispr and cas gene market size has grown exponentially in recent years. It will grow from $3.28 billion in 2023 to $3.97 billion in 2024 at a compound annual growth rate (CAGR) of 21.3%. The growth observed during the historical period can be attributed to several factors, including increased consumer awareness, a shift in consumer values, the rise in celebrity endorsements, the growing popularity of veganism, and increased influence from social media platforms.

The crispr and cas gene market size is expected to see exponential growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 20.5%. The anticipated growth in the upcoming period can be attributed to several factors, including the global expansion of bans on certain ingredients, the rise of conscious consumerism, the emergence of new brands in the market, initiatives focused on consumer education, and the promotion of beauty inclusivity. Key trends expected in the forecast period encompass advancements in technology, product innovations, the development of a circular beauty economy, growth in the men's grooming segment, and an increased focus on social justice and ethical sourcing within the beauty industry.

The anticipated increase in focus on personalized therapy is set to drive the growth of the CRISPR and Cas gene markets in the future. Personalized therapy involves utilizing an individual's genetic profile to inform decisions regarding disease diagnosis, treatment, and prevention. CRISPR and the Cas gene, particularly Cas9, play a pivotal role in personalized medicine by enabling precise modifications to an individual's genetic material, offering potential breakthroughs in tailored therapies for genetic disorders, cancer, and various medical conditions. For example, data from the Personalized Medicine Coalition, a US-based professional membership organization, revealed that in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Among these, approximately 34%, or 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Thus, the growing demand for personalized therapy is expected to fuel the growth of the CRISPR and Cas gene markets.

Key players in the CRISPR and Cas gene markets are actively developing innovative products such as CRISPR-based cell-based gene therapy to enhance their product offerings and gain a competitive edge. CRISPR-based cell-based gene therapy involves utilizing CRISPR gene-editing technology to modify or correct genetic material within cells, presenting a targeted and potentially transformative approach to treating genetic disorders, diseases, and other medical conditions at the cellular level. For instance, in December 2023, Vertex Pharmaceuticals Incorporated, a US-based biopharmaceutical company, obtained approval from the U.S. Food and Drug Administration (FDA) for CASGEVY (exagamglogene autotemcel [exa-cel]). CASGEVY is a CRISPR/Cas9 genome-edited gene therapy indicated for managing sickle cell disease (SCD) in individuals aged 12 and above who experience recurrent vaso-occlusive crises. This first-of-its-kind therapy has the potential to offer a one-time transformative treatment for eligible sickle cell patients. Vertex is collaborating with experienced institutions to establish a network of approved treatment centers (ATCs) across the United States to administer CASGEVY to patients, requiring specific training in stem cell transplantation.

In January 2022, Bayer AG, a Germany-based pharmaceutical company, entered into a collaboration with Mammoth Biosciences to harness the natural richness in advancing the next generation of CRISPR products. This partnership aims to utilize Mammoth's CRISPR systems for developing in vivo gene-editing therapies, enhancing Bayer's emerging cell and gene therapy platform. The collaboration aligns with Mammoth Biosciences' goal of unlocking the full potential of innovative CRISPR systems. Mammoth BioSciences is a US-based biotechnology company specializing in developing CRISPR-Cas gene diagnostic tests.

Major companies operating in the crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group Plc, Beam Therapeutics Inc, Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc, Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.

North America was the largest region in the CRISPR and Cas gene market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the CRISPR and Cas gene market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The CRISPR and Cas gene market consists of revenues earned by entities by offering services such as gene editing, targeted disruption of genes, targeted drug development, livestock breeding, and animal model construction. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR and Cas gene market also includes sales of RNA clean-up kits, phenol-free kits, t7 polymerase mix, and RNAse-free water. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CRISPR And Cas Gene Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crispr and cas gene market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crispr and cas gene ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crispr and cas gene market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Kits And Enzymes; Libraries; Design Tool; Antibodies; Other Products Types
  • 2) By Service Type: Cell Line Engineering; gRNA Design; Microbial Gene Editing; DNA Synthesis
  • 3) By Application: Clinical; Financial; Operational And Administrative
  • 4) By End Use: Biotechnology And Pharmaceutical Companies; Academics And Government Research Institutes; Contract Research Organizations (CROs)
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc; AstraZeneca plc.; Danaher Corporation; Quest Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. CRISPR And Cas Gene Market Characteristics

3. CRISPR And Cas Gene Market Trends And Strategies

4. CRISPR And Cas Gene Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global CRISPR And Cas Gene Market Size and Growth

  • 5.1. Global CRISPR And Cas Gene Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global CRISPR And Cas Gene Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global CRISPR And Cas Gene Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. CRISPR And Cas Gene Market Segmentation

  • 6.1. Global CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Kits And Enzymes
  • Libraries
  • Design Tool
  • Antibodies
  • Other Products Types
  • 6.2. Global CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Line Engineering
  • gRNA Design
  • Microbial Gene Editing
  • DNA Synthesis
  • 6.3. Global CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinical
  • Financial
  • Operational And Administrative
  • 6.4. Global CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biotechnology And Pharmaceutical Companies
  • Academics And Government Research Institutes
  • Contract Research Organizations (CROs)

7. CRISPR And Cas Gene Market Regional And Country Analysis

  • 7.1. Global CRISPR And Cas Gene Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global CRISPR And Cas Gene Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific CRISPR And Cas Gene Market

  • 8.1. Asia-Pacific CRISPR And Cas Gene Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China CRISPR And Cas Gene Market

  • 9.1. China CRISPR And Cas Gene Market Overview
  • 9.2. China CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India CRISPR And Cas Gene Market

  • 10.1. India CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan CRISPR And Cas Gene Market

  • 11.1. Japan CRISPR And Cas Gene Market Overview
  • 11.2. Japan CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia CRISPR And Cas Gene Market

  • 12.1. Australia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia CRISPR And Cas Gene Market

  • 13.1. Indonesia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea CRISPR And Cas Gene Market

  • 14.1. South Korea CRISPR And Cas Gene Market Overview
  • 14.2. South Korea CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe CRISPR And Cas Gene Market

  • 15.1. Western Europe CRISPR And Cas Gene Market Overview
  • 15.2. Western Europe CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK CRISPR And Cas Gene Market

  • 16.1. UK CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany CRISPR And Cas Gene Market

  • 17.1. Germany CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France CRISPR And Cas Gene Market

  • 18.1. France CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy CRISPR And Cas Gene Market

  • 19.1. Italy CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain CRISPR And Cas Gene Market

  • 20.1. Spain CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe CRISPR And Cas Gene Market

  • 21.1. Eastern Europe CRISPR And Cas Gene Market Overview
  • 21.2. Eastern Europe CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia CRISPR And Cas Gene Market

  • 22.1. Russia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America CRISPR And Cas Gene Market

  • 23.1. North America CRISPR And Cas Gene Market Overview
  • 23.2. North America CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA CRISPR And Cas Gene Market

  • 24.1. USA CRISPR And Cas Gene Market Overview
  • 24.2. USA CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada CRISPR And Cas Gene Market

  • 25.1. Canada CRISPR And Cas Gene Market Overview
  • 25.2. Canada CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America CRISPR And Cas Gene Market

  • 26.1. South America CRISPR And Cas Gene Market Overview
  • 26.2. South America CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil CRISPR And Cas Gene Market

  • 27.1. Brazil CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East CRISPR And Cas Gene Market

  • 28.1. Middle East CRISPR And Cas Gene Market Overview
  • 28.2. Middle East CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa CRISPR And Cas Gene Market

  • 29.1. Africa CRISPR And Cas Gene Market Overview
  • 29.2. Africa CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. CRISPR And Cas Gene Market Competitive Landscape And Company Profiles

  • 30.1. CRISPR And Cas Gene Market Competitive Landscape
  • 30.2. CRISPR And Cas Gene Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AstraZeneca plc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Quest Diagnostics
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. CRISPR And Cas Gene Market Other Major And Innovative Companies

  • 31.1. Lonza Group AG
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. eGenesis
  • 31.4. Novartis Institutes for BioMedical Research
  • 31.5. Myriad Genetics Inc.
  • 31.6. GenScript
  • 31.7. Takara Bio Inc.
  • 31.8. 23andMe Inc.
  • 31.9. Merck KGaA
  • 31.10. Color Genomics Inc.
  • 31.11. Horizon Discovery Group Plc
  • 31.12. Beam Therapeutics Inc
  • 31.13. Intellia Therapeutics Inc.
  • 31.14. New England BioLabs
  • 31.15. Recursion Pharmaceuticals Inc

32. Global CRISPR And Cas Gene Market Competitive Benchmarking

33. Global CRISPR And Cas Gene Market Competitive Dashboard

34. Key Mergers And Acquisitions In The CRISPR And Cas Gene Market

35. CRISPR And Cas Gene Market Future Outlook and Potential Analysis

  • 35.1 CRISPR And Cas Gene Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 CRISPR And Cas Gene Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 CRISPR And Cas Gene Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer